PharmaShots | Incisive News in 3 Shots

Subscribe Now

Neuronetics

Neuronetics Receives the US FDA’s 510(k) Clearance of MT Cap Technology to Treat Obsessive-Compulsive Disorder

Neuronetics Receives the US FDA’s 510(k) Clearance of MT Cap Technology to Treat Obsessive-Compulsive Disorder

June 13, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us